Cancer therapy spin out secures additional $85 million
Artios Pharma Limited, a biotech company established with the help and expertise of Francis Crick Institute scientist Simon Boulton, has secured an additional $86m (£65m) to advance its first-in-class small molecule DNA repair programmes into the clinic.
